
TSE:WEED
This summary was created by AI, based on 1 opinions in the last 12 months.
Canopy Growth Corp. has drawn criticism from experts regarding its performance in the cannabis industry. One notable review highlights the company's weak returns on capital, which raises concerns about the substantial capital that has been reportedly invested and subsequently destroyed. The expert suggests that the cannabis sector lacks the necessary regulatory improvements and market stability, which hinders investment decisions. Additionally, there seems to be a call for major consolidation within the industry to enhance the operational efficiency and overall viability of companies like Canopy Growth. Consequently, investors are advised to approach this stock cautiously until the market improves significantly.
The industry looks quite interesting. We don’t get too many opportunities in public markets to invest in an emerging sector like this. You have to be aware that there could be some government challenges along the way. This one seems to be the leader, which is why he chose it. Growth rates look good and he doesn’t think the demand picture is going to be a problem. Thinks that we could see earnings in 2015 that would justify the current valuation.
Medical marijuana. Trades in a fairly volatile fashion. The difficulty he has is that there is huge uncertainty about what will happen to the market, regulations and the court case that happened in BC. There is some possibility that with a change in government, there could be problems. It does look like it has some investor affection. This is “gold rush” time and in a gold rush most people don’t find any gold.
This is pretty early for the sector. One of his observations is that it is less profitable than people think. It is really an agricultural stock with all the risks that are associated with it. Also, there is a lot of hype behind it. He has been Short this one since April. Feels it is overvalued and overhyped. There is going to be more competition for them.